Endurant Capital Management LP
Follow13F filer, CIK 1633055, San Mateo, CA
Endurant Capital Management LP reported $0 across 1 holding for the quarter ended 2024-03-31, in a 13F-HR filed 2024-05-07.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001633055-24-000003
- Period
- 2024-03-31
- Reported value
- $0
- Holdings
- 1
- Top 10 weight
- New
- 1
- Sold out
- 25
Largest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| BSXexited | -39,108 | -$2.26M |
| TMOexited | -3,794 | -$2.01M |
| AXONICS INCexited | -24,871 | -$1.55M |
| ELVexited | -2,627 | -$1.24M |
| ICLRexited | -3,659 | -$1.04M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q1 2024
Share positions as resolved from 13F-HR 0001633055-24-000003, largest first. % of portfolio is the value over $0, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| 00 | 0 | $0 | new | Value filed as zero, left out of ratios.Amount filed as zero, left out of ratios. |
Sold out in Q1 2024
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| BSXBOSTON SCIENTIFIC CORP | 39,108 | $2.26M | shares |
| TMOTHERMO FISHER SCIENTIFIC INC | 3,794 | $2.01M | shares |
| AXONICS INCAXONICS INC | 24,871 | $1.55M | shares |
| ELVELEVANCE HEALTH INC FORMERLY | 2,627 | $1.24M | shares |
| ICLRICON PUB LTD CO | 3,659 | $1.04M | shares |
| LABORATORY CRP OF AMER HLDGSLABORATORY CRP OF AMER HLDGS | 3,984 | $906K | shares |
| EHCENCOMPASS HEALTH CORP | 12,870 | $859K | shares |
| PODDINSULET CORP | 3,906 | $848K | shares |
| HOLXHOLOGIC INC | 11,631 | $831K | shares |
| ZBHZIMMER BIOMET HOLDINGS INC | 5,646 | $687K | shares |
| AVTRAVANTOR INC | 24,598 | $562K | shares |
| THCTENET HEALTHCARE CORP | 7,303 | $552K | shares |
| PFEPFIZER INC | 15,790 | $455K | shares |
| BMRNBIOMARIN PHARMACEUTICAL INC | 4,650 | $448K | shares |
| KIDSORTHOPEDIATRICS CORP | 13,428 | $437K | shares |
| CITHE CIGNA GROUP | 1,384 | $414K | shares |
| QDELQUIDELORTHO CORP | 5,147 | $379K | shares |
| THE COOPER COMPANIESTHE COOPER COMPANIES | 988 | $374K | shares |
| SBRASABRA HEALTH CARE REIT INC | 20,017 | $286K | shares |
| AAGILENT TECHNOLOGIES INC | 1,900 | $264K | shares |
| FTREFORTREA HLDGS INC | 6,988 | $244K | shares |
| QIAGEN NVQIAGEN NV | 5,219 | $227K | shares |
| HUMHUMANA INC | 469 | $215K | shares |
| CORCENCORA INC | 990 | $203K | shares |
| ACRSACLARIS THERAPEUTICS INC | 148,400 | $156K | shares |
How Q1 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001633055-24-000003 | base | 2024-05-07 | acceptance time not in the bulk data set |
Filings
Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001633055-24-000003 | Quarter ended 2024-03-31 | 2024-05-07 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-24-000002 | Quarter ended 2023-12-31 | 2024-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-23-000008 | Quarter ended 2023-09-30 | 2023-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-23-000007 | Quarter ended 2023-06-30 | 2023-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-23-000006 | Quarter ended 2023-03-31 | 2023-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-23-000002 | Quarter ended 2022-12-31 | 2023-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-22-000007 | Quarter ended 2022-09-30 | 2022-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-22-000006 | Quarter ended 2022-06-30 | 2022-08-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-22-000005 | Quarter ended 2022-03-31 | 2022-05-16 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-22-000002 | Quarter ended 2021-12-31 | 2022-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-21-000008 | Quarter ended 2021-09-30 | 2021-11-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001633055-21-000007 | Quarter ended 2021-06-30 | 2021-08-27 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-21-000006 | Quarter ended 2021-06-30 | 2021-08-16 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-21-000004 | Quarter ended 2021-03-31 | 2021-05-17 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-21-000002 | Quarter ended 2020-12-31 | 2021-02-16 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-20-000005 | Quarter ended 2020-09-30 | 2020-11-16 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-20-000003 | Quarter ended 2020-06-30 | 2020-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-20-000002 | Quarter ended 2020-03-31 | 2020-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-20-000001 | Quarter ended 2019-12-31 | 2020-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001633055-19-000007 | Quarter ended 2019-09-30 | 2019-11-25 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-19-000006 | Quarter ended 2019-09-30 | 2019-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-19-000005 | Quarter ended 2019-06-30 | 2019-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-19-000002 | Quarter ended 2019-03-31 | 2019-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-19-000001 | Quarter ended 2018-12-31 | 2019-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-18-000004 | Quarter ended 2018-09-30 | 2018-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-18-000003 | Quarter ended 2018-06-30 | 2018-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-18-000002 | Quarter ended 2018-03-31 | 2018-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-18-000001 | Quarter ended 2017-12-31 | 2018-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-17-000010 | Quarter ended 2017-09-30 | 2017-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-17-000008 | Quarter ended 2017-06-30 | 2017-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-17-000004 | Quarter ended 2017-03-31 | 2017-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-17-000002 | Quarter ended 2016-12-31 | 2017-02-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-16-000012 | Quarter ended 2016-09-30 | 2016-11-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-16-000011 | Quarter ended 2016-06-30 | 2016-08-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-16-000009 | Quarter ended 2016-03-31 | 2016-05-16 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-16-000008 | Quarter ended 2015-12-31 | 2016-02-16 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-15-000006 | Quarter ended 2015-09-30 | 2015-11-16 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-15-000005 | Quarter ended 2015-06-30 | 2015-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-15-000004 | Quarter ended 2015-03-31 | 2015-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001633055-15-000001 | Quarter ended 2014-12-31 | 2015-02-17 | acceptance time not in the bulk data set |